Pharmacyclics Reports Recent Developments and Financial Results for Fiscal Second Quarter 2011
by on Friday, February 4th, 2011 | No Comments
… Pharmacyclics has designed a broad Phase II Program in mantle cell lymphoma, chronic lymphocytic leukemia and diffuse large B-cell lymphoma to inform the Phase III program and regulatory path …
Read more from the original source: Pharmacyclics Reports Recent Developments and Financial Results for Fiscal Second Quarter 2011